andreapriolo10

andreapriolo10

Marker Therapeutics (NASDAQ: MRKR) is a biotech company focused on multi-antigen T cell (MAR-T) therapies targeting hematological malignancies and solid tumors. The company recently published its FY2024 results, highlighting promising clinical progress but also significant financial challenges. As of the end of 2024, Marker reported $19.2 million in cash, with an...

andreapriolo10

The analysis of key levels for the Nasdaq future suggests that the low recorded on January 27, 2025, at 20,763 marks the beginning of a quarterly cycle. If this level holds, it could trigger a sequence of positive daily bars, confirming the bullish structure. However, there are two additional key levels to monitor in order to validate the strength of this...